BELITE BIO INC - ADR (BLTE) Stock Earnings & Estimates
USA - NASDAQ:BLTE - US07782B1044 - ADR
73 USD
+6.1 (+9.12%)
73 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 540.71% | N/A 107.64% | N/A 94.98% | N/A 15.38% | N/A 70.19% | N/A 32.00% | ||||||
| EBITDA YoY % growth | -5.72M | -9.77M -70.80% | -12.76M -30.60% | -31.6M -147.65% | -39.55M -25.16% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.74M | -9.8M -70.73% | -12.82M -30.82% | -32M -149.61% | -40M -25.00% | N/A -69.65% | N/A 14.15% | N/A 87.47% | N/A -31.01% | N/A 1,031.96% | N/A 220.47% | N/A 93.96% | N/A 38.46% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.24 -85.60% | -1.18 4.84% | N/A -68.56% | N/A 23.25% | N/A 160.13% | N/A 189.44% | N/A 207.49% | N/A -47.07% | N/A 91.75% | N/A 50.80% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.50 -78.50% | -0.50 -56.19% | -0.49 -8.05% | -0.49 1.40% | -0.43 13.27% | -0.43 13.27% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.001M -74.55% | -17.087M -55.34% | -16.486M -3.04% | -16.86M -22.58% | -15.566M 8.44% | -15.939M 6.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.50 -61.29% | -0.43 | -0.07 | -17.41% |
| Q1 2025 Q2Q % growth | -0.45 -66.67% | -0.38 | -0.07 | -18.12% |
| Q4 2024 Q2Q % growth | -0.32 -28.00% | -0.31 | -0.01 | -1.93% |
| Q3 2024 Q2Q % growth | -0.28 30.00% | -0.29 | 0.01 | 4.68% |
| Q2 2024 Q2Q % growth | -0.31 -19.23% | -0.26 | -0.05 | -20.25% |
| Q1 2024 Q2Q % growth | -0.27 18.18% | -0.29 | 0.02 | 6.79% |
| Q4 2023 Q2Q % growth | -0.25 32.43% | -0.31 | 0.06 | 18.30% |
| Q3 2023 Q2Q % growth | -0.40 -124.09% | -0.33 | -0.07 | -22.36% |
| Q2 2023 Q2Q % growth | -0.26 -8.47% | -0.30 | 0.04 | 14.32% |
| Q1 2023 Q2Q % growth | -0.33 -13.52% | -0.20 | -0.13 | -61.76% |
| Q4 2022 Q2Q % growth | -0.37 | -0.23 | -0.14 | -61.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.51% | -11.59% | -27.45% |
| Revenue | N/A | N/A | N/A | N/A |